Literature DB >> 19258258

MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature.

Wesley E Bolch1, Keith F Eckerman, George Sgouros, Stephen R Thomas.   

Abstract

The internal dosimetry schema of the Medical Internal Radiation Dose (MIRD) Committee of the Society of Nuclear Medicine has provided a broad framework for assessment of the absorbed dose to whole organs, tissue subregions, voxelized tissue structures, and individual cellular compartments for use in both diagnostic and therapeutic nuclear medicine. The schema was originally published in 1968, revised in 1976, and republished in didactic form with comprehensive examples as the MIRD primer in 1988 and 1991. The International Commission on Radiological Protection (ICRP) is an organization that also supplies dosimetric models and technical data, for use in providing recommendations for limits on ionizing radiation exposure to workers and members of the general public. The ICRP has developed a dosimetry schema similar to that of the MIRD Committee but has used different terminology and symbols for fundamental quantities such as the absorbed fraction, specific absorbed fraction, and various dose coefficients. The MIRD Committee objectives for this pamphlet are 3-fold: to restate its schema for assessment of absorbed dose in a manner consistent with the needs of both the nuclear medicine and the radiation protection communities, with the goal of standardizing nomenclature; to formally adopt the dosimetry quantities equivalent dose and effective dose for use in comparative evaluations of potential risks of radiation-induced stochastic effects to patients after nuclear medicine procedures; and to discuss the need to identify dosimetry quantities based on absorbed dose that address deterministic effects relevant to targeted radionuclide therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258258     DOI: 10.2967/jnumed.108.056036

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  190 in total

1.  An approach for balancing diagnostic image quality with cancer risk: application to pediatric diagnostic imaging of 99mTc-dimercaptosuccinic acid.

Authors:  George Sgouros; Eric C Frey; Wesley E Bolch; Michael B Wayson; Andres F Abadia; S Ted Treves
Journal:  J Nucl Med       Date:  2011-12       Impact factor: 10.057

2.  EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry.

Authors:  Cecilia Hindorf; Gerhard Glatting; Carlo Chiesa; Ola Lindén; Glenn Flux
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06       Impact factor: 9.236

3.  Radiation exposure, protection and risk from nuclear medicine procedures.

Authors:  Massimo Salvatori; Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06       Impact factor: 9.236

4.  EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting.

Authors:  M Lassmann; C Chiesa; G Flux; M Bardiès
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-27       Impact factor: 9.236

5.  Dose escalation and dosimetry of first-in-human α radioimmunotherapy with 212Pb-TCMC-trastuzumab.

Authors:  Ruby Meredith; Julien Torgue; Sui Shen; Darrell R Fisher; Eileen Banaga; Patty Bunch; Desiree Morgan; Jinda Fan; J Michael Straughn
Journal:  J Nucl Med       Date:  2014-08-25       Impact factor: 10.057

6.  Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates.

Authors:  Sangeeta Ray Banerjee; Catherine A Foss; Mrudula Pullambhatla; Yuchuan Wang; Senthamizhchelvan Srinivasan; Robert F Hobbs; Kwamena E Baidoo; Martin W Brechbiel; Sridhar Nimmagadda; Ronnie C Mease; George Sgouros; Martin G Pomper
Journal:  J Nucl Med       Date:  2015-02-26       Impact factor: 10.057

7.  An image-based skeletal dosimetry model for the ICRP reference adult male--internal electron sources.

Authors:  Matthew Hough; Perry Johnson; Didier Rajon; Derek Jokisch; Choonsik Lee; Wesley Bolch
Journal:  Phys Med Biol       Date:  2011-03-22       Impact factor: 3.609

8.  Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model.

Authors:  Jessie R Nedrow; Anders Josefsson; Sunju Park; Tom Bäck; Robert F Hobbs; Cory Brayton; Frank Bruchertseifer; Alfred Morgenstern; George Sgouros
Journal:  EJNMMI Res       Date:  2017-07-18       Impact factor: 3.138

9.  Investigation of factors influencing radioiodine (131I) biokinetics in patients with benign thyroid disease using nonlinear mixed effects approach.

Authors:  Valentina Topić Vučenović; Zvezdana Rajkovača; Dijana Jelić; Dragi Stanimirović; Goran Vuleta; Branislava Miljković; Katarina Vučićević
Journal:  Eur J Clin Pharmacol       Date:  2018-05-13       Impact factor: 2.953

10.  Individualized adjustments to reference phantom internal organ dosimetry-scaling factors given knowledge of patient internal anatomy.

Authors:  Michael B Wayson; Wesley E Bolch
Journal:  Phys Med Biol       Date:  2018-04-13       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.